Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(5 sites)
China
Cancer Institute and Hospital Chinese Academy of Medical Sciences, Beijing, Beijing Municipality Beijing Obstetrics and Gynecology Hospital, Beijing, Beijing Municipality Peking University First Hospital, Beijing, Beijing Municipality Peking Union Medical College Hospital, Beijing, Beijing Municipality The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi Last updated February 2026